Rohto Pharmaceutical Co.L... (RPHCF)

AI Score

Unlock

20.09

-6.54 (-24.56%)

At close: Jan 24, 2025, 8:00 PM

Rohto Pharmaceutical Balance Sheet Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015
Cash & Equivalents	89.21B	580.26M	515.09M	540.94M	584.78M	591.93M	525.63M	568.91M	582.48M	585.46M	625.15M	525.66M	472.9M	49.2B	47.06B	44.42B	45.31B	41.15B	37.47B	36.87B	37.86B	34.25B	30.8B	32.72B	30.53B	27.71B	24.31B	23.66B	23.92B	24.91B	18.5B	23.43B	23.07B	23.64B	26.68B	31.73B
Short-Term Investments	n/a	n/a	15.86M	n/a	17.01M	n/a	14.65M	n/a	15.49M	n/a	n/a	n/a	6.42M	n/a	n/a	n/a	-3.1B	n/a	n/a	n/a	-2.84B	n/a	n/a	n/a	-2.8B	n/a	n/a	n/a	-3.2B	n/a	n/a	n/a	-2.57B	n/a	n/a	n/a
Long-Term Investments	n/a	292.09M	270.2M	262.4M	253.19M	228.45M	198.74M	215.99M	231.1M	239.72M	261.08M	248.01M	267.76M	n/a	n/a	n/a	26.98B	n/a	n/a	n/a	31.37B	n/a	n/a	n/a	35.13B	n/a	n/a	n/a	30.7B	n/a	n/a	n/a	23.98B	n/a	n/a	n/a
Other Long-Term Assets	49.72B	65.4M	61.23M	60.34M	-9.45B	74.67M	71.38M	78.64M	-9.43B	89.07M	88.81M	96.1M	-25.46M	31.45B	31.84B	31.41B	144M	32.08B	34.16B	33.12B	-24M	35.65B	39.24B	39.13B	-598M	39.03B	34.07B	33.83B	-226M	30.72B	28.01B	25.69B	486M	28.27B	26.77B	28.63B
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	46.66B	343.69M	325.13M	322.53M	309.07M	331.09M	293.37M	294.57M	275.42M	301.81M	291.69M	277.32M	252.71M	33.64B	34.2B	33.21B	31.22B	31.95B	30.88B	31.27B	30.26B	32.74B	32.24B	30.25B	26.23B	27.26B	26.12B	25.43B	23.61B	25.52B	25.4B	25.54B	23.04B	26.01B	24.96B	23.74B
Other Current Assets	78.89B	83.82B	79.82B	71.5B	69.23B	73.59B	64.99B	60.43B	57.99B	55.73B	53.23B	45.96B	52.18B	45.67B	48.16B	44.44B	54.18B	50.05B	46.96B	43.03B	48.29B	48.18B	49.62B	45.13B	53.29B	56.74B	54.03B	47.97B	53.41B	45.45B	47.2B	44.22B	55.64B	51.55B	46.65B	36.91B
Total Current Assets	214.76B	1.52B	1.39B	1.36B	1.43B	1.48B	1.28B	1.31B	1.35B	1.37B	1.4B	1.22B	1.2B	128.51B	129.41B	122.07B	130.71B	123.16B	115.31B	111.16B	116.4B	115.17B	112.66B	108.09B	110.05B	111.71B	104.46B	97.07B	100.95B	95.88B	91.11B	93.2B	101.75B	101.2B	98.29B	92.38B
Property-Plant & Equipment	68.61B	484.69M	457.44M	461.97M	498.15M	516.66M	468.03M	487.31M	516.22M	521.17M	538.29M	465.83M	450.59M	49.45B	48.58B	47.98B	48.54B	45.75B	46.08B	46.27B	47.42B	47.93B	48.6B	47.09B	47.19B	46.52B	46.37B	46.2B	45.83B	46.27B	45.92B	47.26B	48.04B	49.53B	50.29B	50.18B
Goodwill & Intangibles	9.22B	9.13B	9.33B	9.47B	9.56B	9.65B	9.81B	9.29B	9.54B	9.32B	7.32B	7.45B	104.52M	5.82B	4.95B	5.02B	5.13B	3.69B	3.91B	3.88B	3.56B	3.47B	3.65B	3.89B	4.11B	2.4B	2.51B	2.57B	2.66B	2.77B	2.87B	3.26B	3.5B	3.61B	3.86B	4.08B
Total Long-Term Assets	131.41B	906.88M	851.31M	850.31M	898.96M	893.36M	805.93M	850.36M	906.29M	930.96M	953.92M	877.05M	839.09M	86.71B	85.37B	84.42B	84.94B	81.51B	84.15B	83.27B	84.55B	87.06B	91.49B	90.1B	88.11B	87.94B	82.94B	82.6B	80.59B	79.76B	76.79B	76.2B	77.82B	81.41B	80.92B	82.9B
Total Assets	346.18B	2.42B	2.24B	2.21B	2.33B	2.38B	2.09B	2.16B	2.26B	2.3B	2.35B	2.09B	2.04B	215.23B	214.79B	206.49B	215.64B	204.67B	199.47B	194.44B	200.95B	202.23B	204.16B	198.19B	198.17B	199.66B	187.41B	179.67B	181.54B	175.64B	167.9B	169.4B	179.57B	182.61B	179.21B	175.28B
Account Payables	16.99B	18.31B	18.61B	20.18B	16.02B	17.8B	17.3B	18.12B	13.66B	15.63B	14.37B	13.54B	9.6B	12.44B	12.44B	12.51B	11.32B	12.41B	11.82B	11.66B	11.01B	12.51B	13.29B	13.71B	12.1B	12.81B	12.1B	11.21B	9.59B	10.6B	10.78B	10.2B	9.8B	10.94B	11.15B	12.27B
Deferred Revenue	n/a	40.99M	37.01M	26.65M	38M	40.45M	32.78M	28.93M	25.11M	40.95M	41.58M	20.2M	44.78M	26.81B	29.27B	27.59B	36.77B	31.15B	32.01B	29.27B	35.62B	31.8B	31.61B	29.2B	34.81B	29.99B	27.92B	25.34B	32.14B	26.3B	26.08B	27.05B	37.14B	32.83B	29.98B	28.19B
Short-Term Debt	5.3B	4.36B	4.17B	4.16B	4.18B	4.71B	5.85B	8.04B	8.03B	7.45B	5.49B	2.93B	2.31B	2.34B	2.57B	2.46B	2.1B	1.95B	1.72B	3.18B	3.75B	4.34B	4.8B	4.66B	4.15B	4.32B	4.23B	3.53B	3.35B	3.52B	3.97B	4.34B	4.45B	5.03B	6.21B	6.31B
Other Current Liabilities	58.15B	-27.86B	-27.75B	-27.64B	-25.83B	-27.2B	-27.36B	-29.52B	-24.29B	41.99B	-23.81B	38.48B	38.42B	35.81B	37.97B	37.29B	42.96B	39.46B	39.32B	37.91B	41.86B	39.78B	39.7B	36.97B	40.63B	37.35B	35.33B	33.54B	37.47B	33.6B	33.45B	35.14B	41.11B	39.51B	37.38B	34.34B
Total Current Liabilities	87.09B	592.71M	555.21M	548.27M	603.38M	609.48M	538.43M	576.73M	587.27M	606.16M	671.31M	515.38M	511.05M	53.31B	55.73B	54.05B	62.12B	57.94B	56.02B	54.66B	60.76B	59.63B	61.46B	58.37B	61.33B	57.21B	53.94B	49.8B	53.42B	49.37B	49.95B	50.66B	59.36B	57.77B	56.43B	53.49B
Long-Term Debt	5.19B	5.27B	5.82B	6.94B	7.52B	10.99B	11.53B	12.76B	13.35B	12.98B	9.33B	7.11B	5.79B	6.33B	6.67B	5.22B	5.19B	1.37B	1.42B	1.22B	1.42B	1.52B	1.57B	1.62B	1.7B	1.75B	1.83B	2.22B	1.76B	1.8B	936M	983M	994M	1.15B	1.22B	1.07B
Other Long-Term Liabilities	2.68B	-5.18B	-5.73B	-6.85B	-8.58B	-10.85B	-11.4B	-12.61B	-14.73B	4.89B	-9.2B	-6.99B	-6.67B	7.81B	8.08B	7.95B	1.32B	7.18B	7.02B	6.81B	1B	6.88B	7.03B	6.95B	249M	9.58B	8.34B	8.03B	230M	8.19B	7.5B	7.66B	273M	8.38B	8B	8.59B
Total Long-Term Liabilities	12.05B	88.68M	88.27M	95.11M	108.64M	140.56M	129.55M	147.23M	158.58M	155.23M	127.27M	126.67M	114.98M	14.15B	14.75B	13.18B	13.5B	8.56B	8.44B	8.04B	8.01B	8.4B	8.6B	8.57B	8.4B	11.33B	10.17B	10.25B	9.69B	9.99B	8.44B	8.64B	8.95B	9.52B	9.22B	9.66B
Total Liabilities	99.14B	681.39M	643.48M	643.38M	712.02M	750.03M	667.98M	723.95M	745.86M	761.39M	798.58M	642.05M	626.03M	67.45B	70.48B	67.22B	75.61B	66.5B	64.46B	62.69B	68.77B	68.03B	70.06B	66.94B	69.73B	68.54B	64.11B	60.05B	63.11B	59.36B	58.39B	59.3B	68.31B	67.29B	65.65B	63.15B
Total Debt	10.49B	68.26M	66.88M	76.94M	102.46M	119.72M	120.07M	153.19M	178.44M	177.51M	133.11M	90.53M	76.82M	8.68B	9.25B	7.69B	7.29B	3.32B	3.14B	4.41B	5.17B	5.86B	6.37B	6.28B	5.85B	6.07B	6.06B	5.75B	5.12B	5.31B	4.91B	5.32B	5.45B	6.18B	7.42B	7.38B
Common Stock	6.5B	46.09M	43.52M	45.06M	48.96M	49.59M	44.92M	47.9M	53.43M	56.49M	58.43M	58.6M	58.86M	6.5B	6.5B	6.5B	6.5B	6.5B	6.5B	6.45B	6.45B	6.45B	6.44B	6.44B	6.42B	6.42B	6.42B	6.42B	6.42B	6.42B	6.42B	6.42B	6.41B	6.41B	6.41B	6.41B
Retained Earnings	209.4B	1.45B	1.32B	1.32B	1.39B	1.37B	1.2B	1.23B	1.33B	1.37B	1.38B	1.33B	1.32B	140.06B	136.68B	132.44B	131.99B	129.12B	125.35B	120.26B	119.99B	121.06B	118.76B	114.88B	112.7B	113.55B	110.35B	106.98B	106.3B	104.81B	101.73B	98.91B	98.67B	97.84B	96.05B	92.5B
Comprehensive Income	n/a	202.4M	189.3M	160.37M	140.79M	165.07M	139.2M	110.32M	71.76M	51.68M	50.4M	50.18M	65.42M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	246.32B	1.7B	1.56B	1.53B	1.58B	1.58B	1.38B	1.39B	1.46B	1.49B	1.5B	1.45B	1.41B	147.11B	143.64B	138.61B	139.28B	137.29B	134.07B	130.81B	131.27B	133.51B	133.4B	130.51B	127.68B	130.68B	122.88B	119.2B	118B	115.89B	109.12B	109.66B	110.81B	114.85B	113.06B	111.71B
Total Investments	44.34B	292.09M	286.06M	262.4M	270.2M	228.45M	213.39M	215.99M	246.6M	239.72M	261.08M	248.01M	274.17M	24.59B	24.62B	24.16B	23.88B	26.62B	29.21B	28.3B	28.53B	30.96B	34.61B	34.42B	32.33B	35.59B	30.19B	29.9B	27.5B	26.12B	23.18B	20.75B	21.41B	23.14B	22.11B	24.02B